{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:52:15Z","timestamp":1791453135334,"version":"4.3.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99786-z","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:33:34Z","timestamp":1748878414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of COVID-19 associated coagulopathy in critically ill patients and the risk of acquired von willebrand syndrome"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-5646","authenticated-orcid":false,"given":"Hiroyasu","family":"Ishikura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Nakashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamagaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hatomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"99786_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3906\/sag-2004-133","volume":"50","author":"L Akin","year":"2020","unstructured":"Akin, L. & G\u00f6zel, M. G. Understanding dynamics of pandemics. Turk. J. Med. Sci. 50, 515\u2013519. https:\/\/doi.org\/10.3906\/sag-2004-133 (2020).","journal-title":"Turk. J. Med. Sci."},{"key":"99786_CR2","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19\u201311 March 2020. World Health Organization. Geneva. (2020). http:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 24 Dec. 2024."},{"key":"99786_CR3","unstructured":"WHO COVID-19 dashboard. Number of COVID-19 cases reported to WHO. Dec. (2024). https:\/\/data.who.int\/dashboards\/covid19\/cases; Accessed 24."},{"key":"99786_CR4","unstructured":"WHO COVID-19 dashboard. Number of COVID-19 deaths reported to WHO. Dec. (2024). https:\/\/data.who.int\/dashboards\/covid19\/deaths; Accessed 24."},{"key":"99786_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","volume":"17","author":"L Perico","year":"2021","unstructured":"Perico, L. et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 17, 46\u201364. https:\/\/doi.org\/10.1038\/s41581-020-00357-4 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"99786_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/02676591211001791","volume":"36","author":"J Kalbhenn","year":"2021","unstructured":"Kalbhenn, J., Glonnegger, H., Wilke, M., Bansbach, J. & Zieger, B. Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series. Perfusion 36, 592\u2013602. https:\/\/doi.org\/10.1177\/02676591211001791 (2021).","journal-title":"Perfusion"},{"key":"99786_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10877-021-00744-7","volume":"36","author":"V Pavoni","year":"2022","unstructured":"Pavoni, V., Gianesello, L., Pazzi, M., Dattolo, P. & Prisco, D. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests. J. Clin. Monit. Comput. 36, 55\u201369. https:\/\/doi.org\/10.1007\/s10877-021-00744-7 (2022).","journal-title":"J. Clin. Monit. Comput."},{"key":"99786_CR8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl. J. Med. 382, 1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032 (2020).","journal-title":"N Engl. J. Med."},{"key":"99786_CR9","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3 (2020).","journal-title":"Lancet"},{"key":"99786_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1358863X20932640","volume":"25","author":"ME Colling","year":"2020","unstructured":"Colling, M. E. & Kanthi, Y. COVID-19-associated coagulopathy: an exploration of mechanisms. Vasc Med. 25, 471\u2013478. https:\/\/doi.org\/10.1177\/1358863X20932640 (2020).","journal-title":"Vasc Med."},{"key":"99786_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","volume":"48","author":"T Iba","year":"2020","unstructured":"Iba, T., Levy, J. H., Levi, M., Connors, J. M. & Thachil, J. Coagulopathy of coronavirus disease 2019. Crit. Care Med. 48, 1358\u20131364. https:\/\/doi.org\/10.1097\/CCM.0000000000004458 (2020).","journal-title":"Crit. Care Med."},{"key":"99786_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12185-023-03555-5","volume":"117","author":"H Ishikura","year":"2023","unstructured":"Ishikura, H. et al. Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19). Int. J. Hematol. 117, 845\u2013855. https:\/\/doi.org\/10.1007\/s12185-023-03555-5 (2023).","journal-title":"Int. J. Hematol."},{"key":"99786_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/jon.12770","volume":"30","author":"V Janardhan","year":"2020","unstructured":"Janardhan, V., Janardhan, V. & Kalousek, V. COVID-19 as a blood clotting disorder masquerading as a respiratory illness: a cerebrovascular perspective and therapeutic implications for stroke thrombectomy. J. Neuroimaging. 30, 555\u2013561. https:\/\/doi.org\/10.1111\/jon.12770 (2020).","journal-title":"J. Neuroimaging"},{"key":"99786_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2020.13372","volume":"324","author":"S Bilaloglu","year":"2020","unstructured":"Bilaloglu, S. Thrombosis in hospitalized patients with COVID-19 in a new York City health system. JAMA 324, 799\u2013801. https:\/\/doi.org\/10.1001\/jama.2020.13372 (2020).","journal-title":"JAMA"},{"key":"99786_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl. J. Med. 383, 120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432 (2020).","journal-title":"N Engl. J. Med."},{"key":"99786_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ahj.2020.10.075","volume":"231","author":"NR Smilowitz","year":"2021","unstructured":"Smilowitz, N. R. et al. Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am. Heart J. 231, 93\u201395. https:\/\/doi.org\/10.1016\/j.ahj.2020.10.075 (2021).","journal-title":"Am. Heart J."},{"key":"99786_CR17","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/cid\/ciab003","volume":"73","author":"M Dalager-Pedersen","year":"2021","unstructured":"Dalager-Pedersen, M. et al. Venous thromboembolism and major bleeding in patients with coronavirus disease 2019 (COVID-19): a nationwide, population- based cohort study. Clin. Infect. Dis. 73, 2283\u20132293. https:\/\/doi.org\/10.1093\/cid\/ciab003 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"99786_CR18","doi-asserted-by":"publisher","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","volume":"377","author":"I Katsoularis","year":"2022","unstructured":"Katsoularis, I. et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study. BMJ 377, e069590. https:\/\/doi.org\/10.1136\/bmj-2021-069590 (2022).","journal-title":"BMJ"},{"key":"99786_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","volume":"136","author":"H Al-Samkari","year":"2020","unstructured":"Al-Samkari, H. et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136, 489\u2013500. https:\/\/doi.org\/10.1182\/blood.2020006520 (2020).","journal-title":"Blood"},{"key":"99786_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura, H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J. Intensive Care. 2, 20. https:\/\/doi.org\/10.1186\/2052-0492-2-20 (2014).","journal-title":"J. Intensive Care"},{"key":"99786_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","volume":"25","author":"M Stockschlaeder","year":"2014","unstructured":"Stockschlaeder, M., Schneppenheim, R. & Budde, U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 25, 206\u2013216. https:\/\/doi.org\/10.1097\/MBC.0000000000000065 (2014).","journal-title":"Blood Coagul Fibrinolysis"},{"key":"99786_CR22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes, A. et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl. J. Med. 378, 1965\u20131975. https:\/\/doi.org\/10.1056\/NEJMoa1800385 (2018).","journal-title":"N Engl. J. Med."},{"key":"99786_CR23","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","volume":"125","author":"PJ Lenting","year":"2015","unstructured":"Lenting, P. J., Christophe, O. D. & Denis, C. V. Von Willebrand factor biosynthesis, secretion, and clearance: connecting the Far ends. Blood 125, 2019\u20132028. https:\/\/doi.org\/10.1182\/blood-2014-06-528406 (2015).","journal-title":"Blood"},{"key":"99786_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0041-1727282","volume":"47","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro, E. J., Henry, B. M., Lippi, G., Increased, V. W. F. & Decreased ADAMTS-13 in COVID-19: creating a milieu for (Micro)Thrombosis. Semin Thromb. Hemost. 47, 400\u2013418. https:\/\/doi.org\/10.1055\/s-0041-1727282 (2021).","journal-title":"Semin Thromb. Hemost."},{"key":"99786_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1538-7836.2008.02917.x","volume":"6","author":"AB Federici","year":"2008","unstructured":"Federici, A. B. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? J. Thromb. Haemost. 6, 565\u2013568. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02917.x (2008).","journal-title":"J. Thromb. Haemost"},{"key":"99786_CR26","first-page":"467","volume":"94","author":"RD Frank","year":"2005","unstructured":"Frank, R. D., Altenwerth, B., Brandenburg, V. M., Nolden-Koch, M. & Block, F. Effect of intravenous high-dose Methylprednisolone on coagulation and fibrinolysis markers. Thromb. Haemost. 94, 467\u2013468 (2005).","journal-title":"Thromb. Haemost"},{"key":"99786_CR27","doi-asserted-by":"publisher","first-page":"e260824","DOI":"10.1136\/bcr-2024-260824","volume":"17","author":"A Garg","year":"2024","unstructured":"Garg, A., Gupta, G., Gupta, R. & Mishra, R. K. Converging pathways: acquired von Willebrand disease in systemic lupus erythematosus with antiphospholipid antibodies presenting with persistent menstrual bleeding. BMJ Case Rep. 17, e260824. https:\/\/doi.org\/10.1136\/bcr-2024-260824 (2024).","journal-title":"BMJ Case Rep."},{"key":"99786_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ajcp\/104.3.264","volume":"104","author":"EJ Favaloro","year":"1995","unstructured":"Favaloro, E. J., Facey, D. & Grispo, L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand\u2019s disease, dependent on differing sensitivity of sample Preparation and differential recognition of high molecular weight VWF forms. Am. J. Clin. Pathol. 104, 264\u2013271. https:\/\/doi.org\/10.1093\/ajcp\/104.3.264 (1995).","journal-title":"Am. J. Clin. Pathol."},{"key":"99786_CR29","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","volume":"105","author":"M Franchini","year":"2020","unstructured":"Franchini, M. & Mannucci, P. M. Acquired von Willebrand syndrome: focused for hematologists. Haematologica 105, 2032\u20132037. https:\/\/doi.org\/10.3324\/haematol.2020.255117 (2020).","journal-title":"Haematologica"},{"key":"99786_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/02676591211001791","volume":"36","author":"J Kalbhenn","year":"2021","unstructured":"Kalbhenn, J., Glonnegger, H., Wilke, M., Bansbach, J. & Zieger, B. Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: A case series. Perfusion 36, 592\u2013602 (2021).","journal-title":"Perfusion"},{"key":"99786_CR31","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s00392-022-02047-6","volume":"111","author":"N Roth","year":"2022","unstructured":"Roth, N. et al. The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI. Clin. Res. Cardiol. 111, 1348\u20131357. https:\/\/doi.org\/10.1007\/s00392-022-02047-6 (2022).","journal-title":"Clin. Res. Cardiol."},{"key":"99786_CR32","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/CCM.0000000000005467","volume":"50","author":"J Kalbhenn","year":"2022","unstructured":"Kalbhenn, J., Glonnegger, H., B\u00fcchsel, M., Priebe, H. J. & Zieger, B. Acquired von Willebrand syndrome and Desmopressin resistance during venovenous extracorporeal membrane oxygenation in patients with COVID-19: a prospective observational study. Crit. Care Med. 50, 1246\u20131255. https:\/\/doi.org\/10.1097\/CCM.0000000000005467 (2022).","journal-title":"Crit. Care Med."},{"key":"99786_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","volume":"5","author":"PD James","year":"2021","unstructured":"James, P. D. et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 5, 280\u2013300. https:\/\/doi.org\/10.1182\/bloodadvances.2020003265 (2021).","journal-title":"Blood Adv."},{"key":"99786_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.healun.2018.03.013","volume":"37","author":"J Kalbhenn","year":"2018","unstructured":"Kalbhenn, J., Schlagenhauf, A., Rosenfelder, S., Schmutz, A. & Zieger, B. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery. J. Heart Lung Transpl. 37, 985\u2013991. https:\/\/doi.org\/10.1016\/j.healun.2018.03.013 (2018).","journal-title":"J. Heart Lung Transpl."},{"key":"99786_CR35","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.bcmd.2020.102526","volume":"87","author":"B Panholzer","year":"2021","unstructured":"Panholzer, B. et al. Acquired von Willebrand syndrome in ECMO patients: a 3-year cohort study. Blood Cells Mol. Dis. 87, 102526. https:\/\/doi.org\/10.1016\/j.bcmd.2020.102526 (2021).","journal-title":"Blood Cells Mol. Dis."},{"key":"99786_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/svn-2020-000652","volume":"5","author":"L Dixon","year":"2020","unstructured":"Dixon, L. et al. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc Neurol. 5, 315\u2013322. https:\/\/doi.org\/10.1136\/svn-2020-000652 (2020).","journal-title":"Stroke Vasc Neurol."},{"key":"99786_CR37","doi-asserted-by":"publisher","first-page":"105428","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105428","volume":"30","author":"F Mousa-Ibrahim","year":"2021","unstructured":"Mousa-Ibrahim, F., Berg, S., Od`TPDetola, O., Teitcher, M. & Ruland, S. Intracranial hemorrhage in hospitalized SARS-CoV-2 patients: a case series. J. Stroke Cerebrovasc. Dis. 30, 105428. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105428 (2021).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"99786_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jocn.2020.08.026","volume":"81","author":"I Fayed","year":"2020","unstructured":"Fayed, I., Pivazyan, G., Conte, A. G., Chang, J. & Mai, J. C. Intracranial hemorrhage in critically ill patients hospitalized for COVID-19. J. Clin. Neurosci. 81, 192\u2013195. https:\/\/doi.org\/10.1016\/j.jocn.2020.08.026 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"99786_CR39","doi-asserted-by":"publisher","first-page":"574694","DOI":"10.3389\/fneur.2020.574694","volume":"11","author":"P Fraiman","year":"2020","unstructured":"Fraiman, P., Godeiro-Junior, C., Moro, E., Cavallieri, F. & Zedde, M. COVID-19 and cerebrovascular diseases: a systematic review and perspectives for stroke management. Front. Neurol. 11, 574694. https:\/\/doi.org\/10.3389\/fneur.2020.574694 (2020).","journal-title":"Front. Neurol."},{"key":"99786_CR40","doi-asserted-by":"publisher","first-page":"e23862","DOI":"10.1097\/MD.0000000000023862","volume":"99","author":"AB Cezar-Junior","year":"2020","unstructured":"Cezar-Junior, A. B. et al. Subarachnoid hemorrhage and COVID-19: association or coincidence? Med. (Baltim). 99, e23862. https:\/\/doi.org\/10.1097\/MD.0000000000023862 (2020).","journal-title":"Med. (Baltim)."},{"key":"99786_CR41","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"ARDS Definition Task Force","year":"2012","unstructured":"ARDS Definition Task Force et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 307, 2526\u20132533. https:\/\/doi.org\/10.1001\/jama.2012.5669 (2012).","journal-title":"JAMA"},{"key":"99786_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus, W. A., Draper, E. A. & Wagner, D. P. Zimmerman. J, E, APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818\u2013829 (1985).","journal-title":"Crit. Care Med."},{"key":"99786_CR43","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent, J. L. et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European society of intensive care medicine. Crit. Care Med. 26, 1793\u20131800. https:\/\/doi.org\/10.1097\/00003246-199811000-00016 (1998).","journal-title":"Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99786-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:33:36Z","timestamp":1748878416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99786-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99786-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following ethics review boards approved the protocol for this study: Fukuoka University Hospital (U20-10-008; registered on 22 October 2020); and Sysmex Corporation (2020\u2009\u2212\u2009242; registered on 13 November 2020). We obtained signed informed consent from the patients or their proxies for publication of this study and the study was conducted in accordance to the principles of the Declaration of Helsinki. A copy of the informed consent document can be provided upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Hiroyasu Ishikura (HI) is a member of the Scientific Standardization Committee for disseminated intravascular coagulation of the Japanese Society for Thrombosis and Hemostasis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}}],"article-number":"19321"}}